GGrantIndex
Sort

261,768 grants matching gene therapy

Metal Chelators and Thiols in Endothelial Function

$1,133,231
Oregon State University · P01 · FY2005 · AT

Myelodysplasia

$1,132,969
Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL

Survey and SEER Data Collection Core

$1,132,916
Nancy K Janz · University Of Michigan At Ann Arbor · P01 · FY2013 · CA

Identifying Roadblocks to Antigen Expression and Enhancing Killing of HIV-Infected Cells That Are Refractory to Clearance

$1,132,909
Sarah Beth Joseph · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI

GENHAT-GENETICS OF HYPERTENSION ASSOCIATED TREATMENTS

$1,132,667
University Of Minnesota Twin Cities · R01 · FY2001 · HL

Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease

$1,132,610
Aaron D. Gitler · Stanford University · R35 · FY2020 · NS

Center for Gene Therapy of Cystic Fibrosis

$1,132,500
John F Engelhardt · University Of Iowa · P30 · FY2015 · DK

Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector

$1,132,346
Sung-Yun Pai · Boston Children'S Hospital · U01 · FY2016 · AI

Nuclear Structure and Gene Expression

$1,132,152
Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2014 · CA

Novel Molecular Therapies of Prostate Cancer

$1,131,982
Dario C. Altieri · Wistar Institute · P01 · FY2013 · CA

Clinical production of viral vectors for cancer gene therapy

$1,131,975
Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA

Preclinical drug development in pancreatic cancer

$1,131,974
Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

NATIONAL FERRET RESOURCE AND RESEARCH CENTER ON LUNG DISEASE

$1,131,912
Jessica Boyle · University Of Iowa · N01 · FY2023 · HL

GROWTH FACTOR RECEPTOR SIGNALING IN BREAST CANCER

$1,131,894
Mien-Chie Hung · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA

Neurodevelopment and Plasticity in Social Neural Circuits

$1,131,858
David A Leopold · National Institute Of Mental Health · ZIA · FY2023 · MH

Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy

$1,131,849
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL

Advanced Imaging Core

$1,131,810
Ronald Petralia · National Institute On Deafness And Other Communication Disorders · ZIC · FY2020 · DC

Bio-Therapies for the Treatment of Cancer and Infectious Disease

$1,131,591
David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance

$1,131,504
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2020 · CA

Nephrotic Syndrome Rare Disease Clinical Research Network

$1,131,454
Matthias Kretzler · University Of Michigan At Ann Arbor · U54 · FY2018 · DK

Cancer Center Support Grant - Core Consolidation Supplement

$1,131,386
Michelle M Le Beau · University Of Chicago · P30 · FY2010 · CA

Histidine phosphorylation as a new target for cancer therapy

$1,131,312
Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2023 · CA

Nephrotic Syndrome Rare Disease Clinical Research Network

$1,131,277
Matthias Kretzler · University Of Michigan At Ann Arbor · U54 · FY2017 · DK

Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes

$1,131,249
Michael Dean · Basic Sciences · Z01 · FY2007 · CA

Severe Chronic Neutropenia International Registry

$1,131,234
Akiko Shimamura · Boston Children'S Hospital · R24 · FY2023 · AI